Taiwan faces yet another year of exclusion from the World Health Assembly (WHA), the central decision-making body of the World Health Organization (WHO), which convenes in Geneva from May 18 to 23. This marks a decade of Taipei not being invited, a situation driven predominantly by China's insistence that Taiwan's involvement must align with its "One China" policy.
However, Taiwan is repositioning its narrative around this exclusion, framing it as a significant issue in global governance as healthcare, artificial intelligence, data management, and technological resilience increasingly converge. Officials in Taipei are making a clear case that excluding one of Asia's leading digital healthcare hubs sends a troubling message, especially as the field of medicine embraces advancements in AI.
Taiwan's Minister of Health and Welfare, Chung-Liang Shih, underscores this notion, stating that in light of the global challenges, including aging populations and healthcare workforce deficits, embracing digital transformation in healthcare is critical. Through the "Healthy Taiwan" initiative, Taipei is centering its national strategy around digital healthcare, leveraging big data, artificial intelligence, and cloud technology to enhance healthcare quality and efficiency.
This political strategy indicates Taiwan's aim to be seen not merely as a democracy sidelined by Chinese influence, but as a vital center of healthcare innovation with the capacity to contribute to global health governance. The Taiwanese government has made considerable investments in integrating digital infrastructure within its healthcare system. Shih describes the “3-3-3 Framework,” a national platform that features healthcare data, interoperable standards, and AI governance, allowing around 400 hospitals to utilize interoperable electronic medical records according to international FHIR standards while employing AI in various medical applications, including chronic disease management and imaging.
Emphasizing cybersecurity, Shih notes that Taiwan's systems allow for secure sharing of healthcare data within a Zero Trust framework, which could be beneficial for the international community. Taiwan is also prioritizing predictive medicine through the “Family Physician Integrated Care Platform,” which uses AI to tailor treatment and promote proactive healthcare management.
In this evolving landscape, Taiwanese authorities recognize the potential of healthcare innovation as a form of soft power on the global stage. Concurrent with the WHA, Taipei plans to hold events in Geneva focused on intelligent healthcare, digital medicine, and its broader medical assistance initiatives. This messaging is particularly targeted toward Western nations, which have gradually intensified their support for Taiwan's international participation while maintaining their respective One China policies.
The European Union has recently endorsed Taiwan's involvement in international organizations "where applicable under organizational rules," subtly countering China's portrayal of universal support for its One China principle. Furthermore, while maintaining diplomatic recognition of Beijing, Brussels is also expanding its collaboration with Taipei in technology and economy.
Taiwan is positioning itself not only as a crucial player in semiconductor supply chains but also as a dependable partner in the governance of emerging sectors such as AI and digital healthcare. Shih highlights the establishment of 19 national centers focused on medical AI, emphasizing clinical validation and governance. So far, more than 50 AI medical tools have gained regulatory approval, and Taiwan is working on federated learning platforms that ensure the validation of AI models while safeguarding sensitive data, with initiatives already in collaboration with Southeast Asian nations.
Amid this healthcare strategy lies a broader geopolitical calculation, as U.S.-China rivalry extends into technological and regulatory domains. Taiwan, closely monitoring the implications of recent diplomatic engagements, is converting its diplomatic challenges into strategic advantages. Recognizing that it cannot match Beijing's traditional geopolitical influence, Taiwan seeks to be perceived as a technologically adept democracy essential to global innovation ecosystems.
Healthcare presents a compelling platform for this approach, especially in a post-pandemic world where health has become intertwined with economic resilience, technological security, and institutional trust. Taiwan's absence from WHO discussions highlights the vulnerabilities of multilateral organizations to geopolitical pressures.
Shih's analysis also challenges Beijing’s interpretation of UN Resolution 2758, which has been employed to limit Taiwan's engagement in international forums. While Western support for Taiwan is becoming more pronounced, the island continues to navigate the complex landscape of global politics, aiming to assert its relevance on the international stage through technological prowess and healthcare advancements.
